Immunopathogenesis of inflammatory bowel disease

被引:16
作者
Dotan, I [1 ]
Mayer, L [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA
关键词
D O I
10.1097/00001574-200207000-00005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease (IBD) is characterized by inflammation that results from the interaction between the various components of the mucosal immune system and the microenvironment. These components-lu}inal antigens, intestinal epithelial cells (IEC), lymphocytes, and cells of the innate and adaptive immune system and their secreted mediators (cytokines and chemokines)-contribute to the cascade of events that ends in intestinal and systemic damage in a genetically predisposed host. The origin of IBD is as yet unknown, but the beginning of the third millennium has brought several new insights into the immune aberrations in IBD. The progress achieved last year in each component of IBD pathogenesis will be reviewed. In each section, an attempt to develop correlations between experimental findings and human disease is made. (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:421 / 427
页数:7
相关论文
共 31 条
[1]   The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat [J].
Ajuebor, MN ;
Hogaboam, GM ;
Kunkel, SL ;
Proudfoot, AEI ;
Wallace, JL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :552-558
[2]  
Brimnes J, 2001, EUR J IMMUNOL, V31, P23, DOI 10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO
[3]  
2-2
[4]   Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice [J].
Burns, RC ;
Rivera-Nieves, J ;
Moskaluk, CA ;
Matsumoto, S ;
Cominelli, F ;
Ley, K .
GASTROENTEROLOGY, 2001, 121 (06) :1428-1436
[5]   The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen [J].
Dalwadi, H ;
Wei, B ;
Kronenberg, M ;
Sutton, CL ;
Braun, J .
IMMUNITY, 2001, 15 (01) :149-158
[6]   Development of chronic colitis is dependent on the cytokine MIF [J].
de Jong, YP ;
Abadia-Molina, AC ;
Satoskar, AR ;
Clarke, K ;
Rietdijk, ST ;
Faubion, WA ;
Mizoguchi, E ;
Metz, CN ;
Al Sahli, M ;
ten Hove, T ;
Keates, AC ;
Lubetsky, JB ;
Farrell, RJ ;
Michetti, P ;
van Deventer, SJ ;
Lolis, E ;
David, JR ;
Bhan, AK ;
Terhorst, C .
NATURE IMMUNOLOGY, 2001, 2 (11) :1061-1066
[7]   Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells [J].
Dwinell, MB ;
Lügering, N ;
Eckmann, L ;
Kagnoff, MF .
GASTROENTEROLOGY, 2001, 120 (01) :49-59
[8]   Immune-bacterial homeostasis in the gut: new insights into an old enigma [J].
Elson, CO ;
Cong, YZ ;
Iqbal, N ;
Weaver, CT .
SEMINARS IN IMMUNOLOGY, 2001, 13 (03) :187-194
[9]   Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease [J].
Hahm, KB ;
Im, YH ;
Parks, TW ;
Park, SH ;
Markowitz, S ;
Jung, HY ;
Green, J ;
Kim, SJ .
GUT, 2001, 49 (02) :190-198
[10]   Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603